Location History:
- Guangdong, CN (2007)
- Shenzhen, CN (2009)
Company Filing History:
3 out of 9 
1 out of 4,304 
1 out of 1 Years Active: 2007-2009
Title: A Closer Look at Inventor Leming Shi and His Contributions to Pharmaceutical Innovations
Introduction: Leming Shi, an accomplished inventor based in Guangdong, China, has made significant strides in the field of pharmaceuticals. With a total of four patents to his name, Shi has focused on developing novel compounds that address critical health issues, particularly in the realms of cancer and metabolic disorders.
Latest Patents: One of Shi's notable inventions is related to benzamide derivatives, identified as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity. This invention details the preparation and pharmaceutical use of these novel derivatives aimed at treating cell proliferative diseases, including cancer and psoriasis. Another significant patent focuses on substituted arylalcanoic acid derivatives, serving as PPAR pan agonists. These compounds are pivotal in managing type 2 diabetes and metabolic syndrome, delivering improved therapeutic profiles compared to traditional PPARgamma agonists.
Career Highlights: Leming Shi has worked with distinguished organizations, notably Shenzhen Chipscreen Biosciences, Ltd. and Tsinghua University. His tenure in these institutions has allowed him to refine his expertise and contribute to cutting-edge research in pharmaceutical sciences. His innovations highlight a commitment to enhancing treatment options for various health concerns.
Collaborations: Throughout his career, Shi has collaborated with esteemed colleagues, including Xian-Ping Lu and Zhibin Li. These partnerships have fostered an environment of creativity and innovation, leading to significant advancements in their respective fields.
Conclusion: Leming Shi's contributions to pharmaceutical innovations are noteworthy, particularly through his patents that address pressing medical conditions. As he continues to work with leading companies and collaborate with fellow researchers, his impact on the pharmaceutical landscape will undoubtedly grow, paving the way for new treatment avenues in healthcare.